Clinical & translational oncology

• 

  Año 2013, Vol. 15, Número 6

  • Nanoemulsions and nanoparticles for non-melanoma skin cancer: effects of lipid materials

    P. Severino, J. F. Fangueiro, S. V. Ferreira, R. Basso, M. V. Chaud, M. H. A. Santana, A. Rosmaninho, E. B. Souto

    • Resumen

    págs. 417-424

    

  • Comprehensive overview of the efficacy and safety of sorafenib in advanced or metastatic renal cell carcinoma after a first tyrosine kinase inhibitor

    Francisco Javier Afonso Afonso, Urbano Anido Herranz, Ovidio Fernández Calvo, Sergio Vázquez Estévez, Luis León Mateos, Martin Lázaro Quintela, Manuel Ramos Vázquez, Luis Antón Aparicio

    • Resumen

    págs. 425-433

    

  • Comparisons of 5-aminolevulinic acid photodynamic therapy and after-loading radiotherapy in vivo in cervical cancer

    T. Gui, Y. Wang, Y. Mao, J. Liu, S. Sun, D. Cao, Jiaxin Yang, Keng Shen

    • Resumen

    págs. 434-442

    

  • Intraoperative radiotherapy for the treatment of resectable locally advanced gastric adenocarcinoma: topography of locoregional recurrences and long-term outcomes

    Felipe A. Calvo Manuel, C. Solé, R. Obregón, M. Gómez Espí, Carmen González San Segundo, Luis González Bayón, E. Álvarez Fernández, José Luis García Sabrido

    • Resumen

    págs. 443-449

    

  • Pilot study of feasibility and dosimetric comparison of prone versus supine breast radiotherapy

    Eva Fernández Lizarbe, Angel Montero, Alfredo Polo Rubio, R. Hernanz, R. Morís, S. Formenti, A. Ramos Aguerri

    • Resumen

    págs. 450-459

    

  • Preoperative treatment with bevacizumab in combination with chemotherapy in patients with unresectable metastatic colorectal carcinoma

    Juan Figueras Felip, Santiago López Ben, María Alsina Maqueda, J. Soriano, X. Hernández Yagüe, María Teresa Albiol Quer, R. Guardeño, A. Codina Barreras, Bernardo Queralt

    • Resumen

    págs. 460-466

    

  • Safety and efficacy of metronomic non-pegylated liposomal encapsulated doxorubicin in heavily pretreated advanced breast cancer patients

    Luis Manso Sánchez, N. Valdiviezo, Juan Manuel Sepúlveda Sánchez, Eva Ciruelos, César Mendiola Fernández, Ismael Ghanem Cañete, Estela Vega Alonso, R. Manneh, Miriam Dorta Suárez, Hernán Cortés-Funes

    • Resumen

    págs. 467-471

    

  • Is it necessary to dissect the lymph nodes around an abnormal hepatic artery in D2 lymphadenectomy for gastric cancer?

    Y. Huang, C. Liu, J. L. Lin, G. C. Mu, Y. Zeng

    • Resumen

    págs. 472-476

    

  • Prevalence and management of anaemia in patients with non-myeloid cancer undergoing systemic therapy: a Spanish survey

    Juan Luis Steegmann Olmedillas, José Miguel Sánchez Torres, Ramón Colomer Bosch, Á. Vaz, Javier López Jiménez, José Ignacio Jalón López, Mariano Provencio Pulla, Antonio González Martín, M. Pérez

    • Resumen

    págs. 477-483

    

  • Stereotactic ablative radiotherapy delivered by image-guided helical tomotherapy for extracranial oligometastases

    C. Solé, José Luis López Guerra, Raul Matute, Javier Jaen, Fernando Puebla, Eleonor Rivín del Campo, A. Sánchez Reyes, César Beltrán, Céline Bourgier, Felipe A. Calvo Manuel, Hugo Marsiglia

    • Resumen

    págs. 484-491

    

  • A novel peptide (Thx) homing to non-small cell lung cancer identified by ex vivo phage display

    A. Koivistoinen, I. I. K. Ilonen, K. Punakivi, J. V. Räsänen, H. Helin, E. I. Sihvo, M. Bergman, J. A. Salo

    • Resumen

    págs. 492-498

    

  • Erratum to: Comprehensive overview of the efficacy and safety of sorafenib in advanced or metastatic renal cell carcinoma after a first tyrosine kinase inhibitor

    Francisco Javier Afonso Afonso, Urbano Anido Herranz, Ovidio Fernández Calvo, Sergio Vázquez Estévez, Luis León Mateos, Martin Lázaro Quintela, Manuel Ramos Vázquez, Luis Antón Aparicio

    pág. 499